CAH (Cardinal Health, Inc.) Stock Financials & Earnings

CAHCardinal Health, Inc.

Mkt Cap$52B

Revenue (TTM)$244.5B

Net Income (TTM)$1.7B

EPS (TTM)$6.95

Free Cash Flow (TTM)$5.5B

Gross Margin3.6%

Op. Margin1.0%

Net Margin0.7%

FCF Margin2.3%

P/S Ratio (TTM)0.2x

P/E Ratio (TTM)31.0x

YoY Rev Growth+10.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q3 23	$50.5B	$1.8B	$572M
Q4 23	$53.5B	$1.8B	$137M
Q1 24	$54.6B	$1.7B	-$32M
Q2 24	$57.4B	$1.8B	$505M
Q3 24	$54.9B	$1.9B	$369M
Q4 24	$59.7B	$1.9B	$408M
Q1 25	$52.3B	$1.9B	$568M
Q2 25	$55.3B	$1.9B	$549M
Q3 25	$54.9B	$2.1B	$730M
Q4 25	$60.2B	$2.2B	$428M
Q1 26	$64.0B	$2.3B	$668M
Q2 26	$65.4B	$2.2B	$707M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Cardinal Health At Home Solutions	Medical Member	Nuclear Precision Health Services	Pharmaceutical Member	Gmpd	Other Operating Segment
Q3 23	$650M	$3.0B	$312M	$46.5B	—	—
Q4 23	$654M	$3.1B	$322M	$49.4B	—	—
Q1 24	$684M	$3.1B	$324M	$50.7B	—	—
Q2 24	$761M	$3.2B	$330M	$53.2B	—	—
Q3 24	—	—	—	$50.7B	$3.1B	$1.2B
Q1 25	—	—	—	$48.0B	$3.1B	$1.2B
Q2 25	—	—	—	$50.8B	$3.2B	$1.3B
Q3 25	—	—	—	$50.4B	$3.2B	$1.3B
Q4 25	—	—	—	$55.4B	$3.2B	$1.6B
Q2 26	—	—	—	$60.7B	$3.3B	$1.7B

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 23	$4.0B	$0	$4.0B
Q4 23	$4.1B	$0	$4.1B
Q1 24	$3.9B	$0	$3.9B
Q2 24	$4.6B	$0	$4.6B
Q3 24	$3.7B	$0	$3.7B
Q4 24	$5.1B	$0	$5.1B
Q1 25	$2.9B	$0	$2.9B
Q2 25	$3.8B	$0	$3.8B
Q3 25	$3.3B	$0	$3.3B
Q4 25	$3.9B	$0	$3.9B
Q1 26	$4.6B	$0	$4.6B
Q2 26	$2.8B	$0	$2.8B

Shares Outstanding

Revenue Per Employee

Revenue / Employee